España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
AstraZeneca
AZNCF
OTCPK
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$134.98
2.85
2.16%
At close: -
$133.86
-1.12
-0.83%
After Hours: Jan 10, 4:30 PM EDT
Get Report
Comment
AstraZeneca (AZNCF) Forecast
News
Earnings
AstraZeneca (AZNCF) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for AstraZeneca (OTC:AZNCF) Stock
AstraZeneca Stock (OTC: AZNCF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, August 20, 2024
China's National Medical Products Association...
Benzinga Newsdesk
Friday, August 16, 2024
FDA Approves AstraZeneca's Imfinzi (Durvaluma...
Benzinga Newsdesk
Thursday, August 15, 2024
The FDA Has Accepted Under Priority Review As...
Benzinga Newsdesk
Wednesday, August 14, 2024
The European Union Has Approved AstraZeneca's...
Benzinga Newsdesk
Tuesday, January 02, 2024
AstraZeneca And Sanofi's Beyfortus (Nirsevima...
Benzinga Newsdesk
Tuesday, November 14, 2023
China Approves AstraZeneca's Imfinzi (Durvalu...
Benzinga Newsdesk
Monday, September 11, 2023
AztraZeneca's Tagrisso Plus Chemotherapy Exte...
Benzinga Newsdesk
AstraZeneca, Daiichi Sankyo's Datopotamab Der...
Benzinga Newsdesk
Wednesday, September 06, 2023
The FDA Issued A Complete Response Letter Reg...
Benzinga Newsdesk
Friday, July 28, 2023
AstraZeneca Abandons Blood Cancer, Cardiovascular Programs Amid Portfolio Prioritization
Vandana Singh
AstraZeneca Q2 Earnings Beat Consensus Despite Zero COVID-19 Vaccine Sales, Stock Shoots Up
Vandana Singh
Ionis Has Expanded Its Existing Collaboration...
Benzinga Newsdesk
Alexion, AstraZeneca Rare Disease Agreed To P...
Benzinga Newsdesk
Thursday, July 27, 2023
AstraZeneca's Soliris (Eculizumab) Has Been A...
Benzinga Newsdesk
Tuesday, July 18, 2023
AstraZeneca-Sanofi's Respiratory Syncytial Virus Treatment Scores FDA Approval To Prevent Infection In Infants
Vandana Singh
Monday, July 03, 2023
AstraZeneca Shares Under Pressure On Some Adverse Events In Late-Stage Lung Cancer Drug Trial
Vandana Singh
Thursday, June 29, 2023
AstraZeneca's Imfinzi/Imjudo Combo Shows Sustained Overall Survival Benefit At Four Years In Liver Cancer
Vandana Singh
Monday, June 26, 2023
AstraZeneca Seeks Expanded Use For Soliris As First Targeted Therapy For Pediatric Patients With Autoimmune Neuromuscular Disease
Vandana Singh
Wednesday, June 21, 2023
Why Are Pieris Pharmaceuticals Shares Tanking Today
Vandana Singh
Tuesday, June 20, 2023
AstraZeneca Mulls China Business Unit Spin-Off Amid Geopolitical Tensions
Vandana Singh
Monday, June 12, 2023
The FDA Has Granted Priority Review To AstraZ...
Benzinga Newsdesk
Friday, June 09, 2023
AstraZeneca's Add On Treatment With Standard Care Improves Hemoglobin Levels In Rare Blood Disorder
Vandana Singh
AstraZeneca Inks Over $2B Agreement For Cell Therapies Targeting Diabetes
Vandana Singh
Unanimous Support for AstraZeneca and Sanofi's Nirsevimab: Next Generation RSV Treatment on the Horizon
Vandana Singh
Monday, June 05, 2023
AstraZeneca's Tagrisso Significantly Enhances Survival in Certain Post Surgery Non-Small Cell Lung Cancer Patients
Vandana Singh
Friday, May 26, 2023
AstraZeneca/Merck's Cancer Drug Combo Shows Positive Results In Endometrial Cancer
Vandana Singh
Friday, May 19, 2023
AstraZeneca's China Executive Seeks Loyalty to "Love the Communist Party" In China
Vandana Singh
Wednesday, May 17, 2023
One More Quits US Pharma Lobby Group: AstraZeneca Follows Teva, AbbVie Footsteps
Vandana Singh
AstraZeneca' Tagrisso/Chemo Combo Therapy Delays Treatment Resistance, Disease Progression In Certain Type Of Advanced Lung Cancer
Vandana Singh
Astrazeneca's Tagrisso (Osimertinib) Combined...
Benzinga Newsdesk
Friday, May 12, 2023
Sanofi, AstraZeneca Release Real-World Data For Respiratory Syncytial Virus Antibody
Vandana Singh
Wednesday, May 10, 2023
The European Union Has Approved Astrazeneca's...
Benzinga Newsdesk
Wednesday, May 03, 2023
Sernova Has Entered Into A Preclinical Resear...
Benzinga Newsdesk
Monday, May 01, 2023
FDA Advisory Committee Votes Favoring Restricted Use Of AstraZeneca/Merck's Prostate Cancer Drug
Vandana Singh
Thursday, April 27, 2023
FDA Casts Doubt on Merck/AstraZeneca's Cancer Drug for Prostate Cancer Ahead of Adcomm Meeting
Vandana Singh
AstraZeneca's COVID-19 Vaccine Loses Shine, Cancer Drug Imfinzi & Emerging Markets Stabilize Q1 Revenues
Vandana Singh
Monday, April 24, 2023
AstraZeneca, Ionis Unveil Complete Phase 3 Data For ATTR Candidate, Says Drug Halts Disease Progression
Vandana Singh
Tuesday, April 18, 2023
Why AstraZeneca Shares Are Trading Higher Today?
Vandana Singh
Monday, April 10, 2023
Canadian Cancer Diagnostic Company BioMark Working On Early Lung Detection Assay
Vandana Singh
Wednesday, April 05, 2023
AstraZeneca' Cancer Drug Combo Meets Goal In Late-Stage Ovarian Cancer Study
Vandana Singh
Wednesday, March 29, 2023
Pieris Pharma Pushes Elarekibep Data Readout, Investors React Negatively
Vandana Singh
AstraZeneca Axes Pneumonia Drug Pact With Aridis
Vandana Singh
Monday, March 27, 2023
AstraZeneca-Ionis Partnered Rare Disease Drug Data Shows Sustained Benefit; Drug Under FDA Review
Vandana Singh
Thursday, March 09, 2023
AstraZenceca's Tagrisso Shows Survival Benefit In Early-Stage Lung Cancer Settings
Vandana Singh
AstraZeneca's Immunotherapy Imfinzi Shows Improvement In Survival Chances In Lung Cancer Patients
Vandana Singh
Monday, March 06, 2023
AstraZeneca-Daiichi Sankyo's Flagship Cancer Drug Shows Meaningful, Durable Responses In Other Solid Tumor Setting
Vandana Singh
Tuesday, February 14, 2023
Astrazeneca's Bi-specific Antibody, Rilvegost...
Benzinga Newsdesk
Thursday, February 09, 2023
AstraZeneca Forecasts Growth In 2023 Earnings, Revenue Despite Fall In COVID-19 Products, Plans To Deliver 15 New Medicines This Decade
Vandana Singh
Wednesday, January 11, 2023
AstraZeneca's New Asthma Treatment for Adults Gets Green Light from FDA
Vandana Singh
Monday, January 09, 2023
AstraZeneca To Acquire CinCor Pharma To Strengthen Cardiorenal Pipeline
Vandana Singh
Show More
